Question 121 marks
Question
The enzyme β-galactosidase catalyses the breakdown of the compound ONPG (o-nitrophenyl 1-D-galactopyranoside) to the compound ONP (o-nitrophenyl), as shown in Fig. 1.1. β-galactosidase ONPG ONP + galactose (colourless substrate) (yellow product) Fig. 1.1 As ONP is produced, the colour of the reaction mixture changes to yellow. The intensity of the yellow colour produced is proportional to the concentration of ONP. A colorimeter is used to measure the absorbance of the reaction mixture. Absorbance is a measure of the light absorbed by a coloured solution. In the reaction shown in Fig. 1.1, the more intense the yellow colour, the higher the absorbance. (a) A student was provided with a stock solution of the enzyme β-galactosidase. The student diluted this by a factor of 20 using a buffer solution of pH 8. The student made a final volume of 10 cm3 of dilute β-galactosidase solution. Describe how the student prepared the 10 cm3 of diluted β-galactosidase solution. …… [2] The student investigated the effect of substrate concentration on the enzyme-catalysed reaction shown in Fig. 1.1. (b) The student was provided with: • the diluted β-galactosidase solution prepared in step (a), which was kept cold until needed • a stock solution of 1.0% ONPG made up in a buffered solution of pH 8.0 • a buffer solution of pH 8.0. The procedure used by the student is outlined in step 1 to step 3. 1. The diluted β-galactosidase solution was mixed with 1.0% ONPG solution. 2. After 2 minutes a colorimeter was used to measure the absorbance of this mixture. 3. Steps 1 and 2 were repeated using different concentrations of ONPG solution. (i) Suggest why the student used a colorimeter to measure the absorbance rather than judging the intensity of the colour by eye. …… [1] (ii) Identify the independent variable and the dependent variable in this investigation. independent variable …… dependent variable …… [2] The student used the absorbance values at 2 minutes as the initial rates of reaction. Fig. 1.2 shows the results. initial rate of reaction percentage concentration of ONPG Fig. 1.2 (c) The student decided to investigate the effect of inhibitors on the reaction shown in Fig. 1.1. The student planned to add an inhibitor, inhibitor X, to reaction mixtures containing different concentrations of ONPG solution. (i) Describe a method the student could use to collect the data needed to test the effect of inhibitor X in reaction mixtures containing different concentrations of ONPG solution. The description of your method should be set out in a logical way and be detailed enough for another person to follow. You should not repeat the details from (a) describing how to dilute the stock solution of β-galactosidase. …… [8] Fig. 1.3 shows the results when no inhibitor X was added. no inhibitor X initial rate of reaction percentage concentration of ONPG Fig. 1.3 The student suggested that inhibitor X was acting as a competitive inhibitor. (ii) On Fig. 1.3, sketch the curve expected if inhibitor X was acting as a competitive inhibitor. [2] Vmax is the maximum initial rate of reaction of the enzyme. The Michaelis-Menten constant, Km, is the substrate concentration at which the initial rate of reaction is half its maximum value, Vmax. (iii) Draw on Fig. 1.3 the positions of Vmax and Km of the enzyme when no inhibitor X is present. [2] (iv) Use your graph to describe the effect of the addition of inhibitor X on the Km of this enzyme. …… [1] (d) Acid reflux is a condition where some of the stomach contents are forced back up into the oesophagus (gullet). The main symptom is a burning pain in the oesophagus due to the acidic contents of the stomach. Acid reflux that happens more than twice a week is called gastroesophageal reflux disease (GERD). Two main types of drug are used to treat GERD: • proton pump inhibitors (PPIs) • H2 receptor antagonists (H2RAs). Scientists carried out trials to investigate the effect of these drugs on the relief of acid reflux symptoms in people suffering with GERD. • 200 people were randomly divided into two groups, A and B. • People in group A were given the PPI medication. • People in group B were given the H2RA medication. • The trial lasted for 16 weeks. • In weeks 4, 8, 12 and 16, the people were asked to score their symptoms, using the scale shown in Table 1.1. Table 1.1 scale symptom 1 none 2 minimal 3 mild 4 moderate 5 moderately severe 6 severe 7 very severe • Mean values for each of the treatments A and B were calculated for weeks 4, 8, 12 and 16. • People with a score of 1 were classified as showing removal of symptoms. • People with a score of 2 or 3 were classed as showing improvement of symptoms. The results of these trials are shown in Fig. 1.4 and Fig. 1.5. removal of symptoms 60 60 40 40 Key mean number of PPI people reporting removal of H2RA symptoms 20 20 error bars: 95% CI 0 0 4 weeks 8 weeks 12 weeks 16 weeks weeks after starting treatment Fig. 1.4 improvement of symptoms 100 100 80 80 Key PPI 60 60 mean number of H2RA people reporting error bars: 95% CI improvement of symptoms 40 40 20 20 0 0 4 weeks 8 weeks 12 weeks 16 weeks weeks after starting treatment Fig. 1.5 The scientists analysed the data and concluded that PPIs should be used to treat acid reflux rather than H2RAs. With reference to the data in Fig. 1.4 and Fig. 1.5, discuss the conclusion that PPIs should be used to treat acid reflux. …… [3] [Total: 21]
Mark scheme
1(a) 0.5 cm3 of the stock solution ; 2 idea of adding 9.5 cm3 of buffer / water / filling to the 10 cm3 mark with buffer / water (in a volumetric flask) ; 1(b)(i) idea that (result / it, is) quantitative / AW ; ora 1 1(b)(ii) independent variable: 2 concentration of ONPG / substrate ; dependent variable: absorbance (on colorimeter) ; 1(c)(i) any eight from: 8 1 ref. to preparing / using at least five concentrations of ONPG 2 stated range of five dilutions, from 1%v down, with % units 3 method of keeping β-galactosidase / enzyme, cold (prior to use) ; 4 idea of bringing enzyme and substrate to temperature / equilibrating, before mixing ; 5 method of keeping reactants / reaction mixture, at, constant / controlled / stated / standardised, temperature ; 6 same / constant / stated / standardised / known, volume / concentration / mass of, X / inhibitor ; 7 same / constant / stated / standardised / known, volume of, ONPG / substrate ; 8 same / constant / stated / standardised / known, volume / concentration, of β-galactosidase / enzyme ; 9 ref. to measuring absorbance / intensity of colour (on colorimeter) after one set time ; 10 additional detail of use of colorimeter ; 11 repeat at least twice / three replicates, and calculate mean ; 12 idea of repeating, whole experiment / range of concentrations, without X / inhibitor ; 13 named hazard and risk and precaution ; 1(c)(ii) 1 curve, to the right of / below, original curve ; 2 2 curve / line, must meet the plateau of original curve on the graph ; 1(c)(iii) 1 correct placement of Vmax ; 2 2 correct placement of Km ; 1(c)(iv) (reaction with competitive inhibitor / X) has higher / has increased / increases, Km value (compared to no inhibitor) ; 1 1(d) assume ref. to PPI unless specific treatment stated 3 any three from: 1 idea that PPI overall is more effective / is immediately effective, on improvement / removal (of symptoms) ; 2 either at 12 and 16 weeks / later, overlap of error bars means difference (in effect between PPI and H2RA) is not significant ; or at 4 and 8 weeks / earlier, no overlap of error bars – suggesting difference (in effect, between PPI and H2RA) may be, significant ; 3 no statistical test to compare groups / t test, done (to test for significance) ; 4 idea that H2RA is catching up / may be better in the long term ; 5 AVP ; ; any two from: • less than 50% patients reported no symptoms • no information on severity of symptoms pre-trial • no data on side effects • size of the two test groups not given • no data on long term effects (where H2RA may be better)